Spinal muscular atrophy in Brazil: from individual treatment to global management

Spinal muscular atrophy in Brazil: from individual treatment to global management

Saved in:

Bibliographic Details
Main Authors:	Laurent Servais, Cristiane Araujo Martins Moreno
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Jornal de Pediatria
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755724001384
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Why should a 5q spinal muscular atrophy neonatal screening program be started?
by: Michele Michelin Becker, et al.
Published: (2024-10-01)

Biomarkers in spinal muscular atrophy
by: Liping Yan, et al.
Published: (2025-07-01)

Newborn screening for spinal muscular atrophy in Ukraine: from pilot project to national programme
by: Nataliia Olkhovych, et al.
Published: (2025-07-01)

The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
by: Marianna Maretina, et al.
Published: (2024-10-01)

Reviews of spinal muscular atrophy in Taiwan
by: Yung-Hsiu Lu, et al.
Published: (2024-12-01)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
by: Dimitrios Stoimenis, et al.
Published: (2019-01-01)

Rehabilitation management for patients with spinal muscular atrophy: a review
by: Wei Song, et al.
Published: (2025-07-01)

Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series
by: Melissa D. Svoboda, et al.
Published: (2025-07-01)

Molecular mechanism of neurodegeneration in spinal muscular atrophy
by: A. I. Vlasenko, et al.
Published: (2024-09-01)

Proximal spinal muscular atrophy 5q
by: article Editorial
Published: (2020-12-01)

Clinical and biochemical polymorphism of spinal muscular atrophy
by: M. G. Sokolova, et al.
Published: (2017-03-01)

Spinal Muscular Atrophy Diagnosed by Newborn Screening
by: Matias Lopez-Chacon, et al.
Published: (2019-12-01)

Acute Onset Infantile Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (2001-07-01)

MicroRNAs as Biomarkers in Spinal Muscular Atrophy
by: Maruša Barbo, et al.
Published: (2024-10-01)

The path from theory to practice in the diagnosis and treatment of patients with spinal muscular atrophy
by: article Editorial
Published: (2024-07-01)

Dificuldades diagnósticas na atrofia muscular espinhal Spinal muscular atrophy diagnostic difficulties
by: Alexandra Prufer de Q-C. Araújo, et al.
Published: (2005-03-01)

Longitudinal efficacy of risdiplam treatment in Chinese children with spinal muscular atrophy
by: Yue Yan, et al.
Published: (2025-07-01)

Familial adult spinal muscular atrophy associated with the VAPB gene: report of 42 cases in Brazil
by: Victor Kosac, et al.
Published: (2013-10-01)

Adult spinal muscular atrophy: problems of early diagnosis
by: Yu. A. Shpilyukova, et al.
Published: (2022-12-01)

Diagnostic criteria for spinal muscular atrophy 5q
by: I. V. Sharkova, et al.
Published: (2021-12-01)

Analysis of Eye Movements in Adults with Spinal Muscular Atrophy
by: Marek Krivošík, et al.
Published: (2025-03-01)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)

The evolution and future of respiratory care for Spinal Muscular Atrophy
by: Carrie K Barker, et al.
Published: (2025-03-01)

Spinal muscular atrophy is also a disorder of spermatogenesis
by: Armelle Magot, et al.
Published: (2024-12-01)

Preliminary psychometric validation of patient-reported outcomes relevant to individuals with spinal muscular atrophy and their caregivers
by: Maria Grazia Cattinari, et al.
Published: (2025-06-01)

Clinical Commentary: Obstetric and Respiratory Management of Pregnancy with Severe Spinal Muscular Atrophy
by: Daniel Flunt, et al.
Published: (2009-01-01)

Unraveling the genetic mysteries of spinal muscular atrophy in Chinese families
by: Shanshan Gao, et al.
Published: (2025-01-01)

Economic burden of spinal muscular atrophy: an analysis of claims data
by: Lisa Belter, et al.
Published: (2020-01-01)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
by: Li-Kai Tsai
Published: (2012-01-01)

ECG tremors and polyminimyoclonus of spinal muscular atrophyType-III
by: Pradeep Kumar Gunasekaran, et al.
Published: (2023-11-01)

Health economic evaluation of risdiplam in patients with spinal muscular atrophy
by: А. S. Kolbin, et al.
Published: (2021-10-01)

Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns
by: S. B. Artemyeva, et al.
Published: (2024-03-01)

Factors modifying the course of spinal muscular atrophy 5q
by: M. A. Akhkiamova, et al.
Published: (2024-01-01)

Spinal muscular atrophy is more than a movement disorder
by: article Editorial
Published: (2024-07-01)

Spinal and bulbar muscular atrophy (Kennedy’s disease): case description
by: A. V. Gavrichenko, et al.
Published: (2020-02-01)

Therapeutic advances in 5q-linked spinal muscular atrophy
by: Umbertina Conti Reed, et al.

Recent Advance in Disease Modifying Therapies for Spinal Muscular Atrophy
by: Li-Kai Tsai, et al.
Published: (2024-07-01)

Anaesthetic management of spinal muscular atrophy in a patient with pneumothorax: a case report
by: Madeeha Rasheed, et al.
Published: (2025-03-01)

The Life-Saving Impact of Early Diagnosis and Treatment for Spinal Muscular Atrophy Type 1
by: Almas Siddique, et al.
Published: (2025-04-01)

Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment
by: Yiğithan Güzin, et al.
Published: (2024-11-01)